Second Acquisition in Months Demonstrates Commitment to Addressing Unmet Needs in Stroke IRVINE, California, April 10, 2017 /PRNewswire/ -- Codman Neuro today announced the acquisition of Neuravi ...
Astrazeneca AB has disclosed CX3C chemokine receptor 1 (CX3CR1; CMKBRL1; GPR13) antagonists reported to be useful for the treatment of heart failure, among others. From glaucoma to Stargardt disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results